I understand your concern, but that's like saying that we shouldn't study the drug formulary at this table, as was recommended before, because drugs are changing every day. I think we have a responsibility here to take a look at these issues in totality, whether that be a drug formula, as others of your colleagues have suggested, or whether that be looking at diabetes, which again is an evolving disease entity that we have different treatments for. I think this should be treated in the same manner.
On February 17th, 2016. See this statement in context.